Download PDF
Thromb Haemost 1994; 72(06): 985
DOI: 10.1055/s-0038-1648994
Letter to the Editor
Schattauer GmbH Stuttgart

Comments on Plasma Fibrinogen Levels Measured by Functional Methods

Boguslaw Lipinski
1   H. S. Research Laboratory, Cambridge, MA, USA
,
Scott Federman
2   Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA
,
Andrzej S Krolewski
2   Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA
› Author Affiliations
Further Information

Publication History

Received 14 June 1994

Accepted 05 August 1994

Publication Date:
06 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Ceriello A, Pirisi M, Giacomello R, Stel G, Failed E, Motz E, Lizzio S, Gonano F, Bartoli E. Fibrinogen plasma levels as a marker of thrombin activation. New insights on the role of fibrinogen as a cardiovascular risk factor Thromb Haemost 1994; 71: 593-595
    PubMedGoogle Scholar
  • 2 Ceriello A, Quatraro A, Ettorre M, Barbanti M, Giugliano D. Glycosamoino-glycans administration decreases high fibrinogen plasma levels in diabetic patients. Diab Nutr Metab 1993; 6: 203-206
    PubMedGoogle Scholar
  • 3 Lipinski B, Federman SM, Krolewski AS. Macromolecular protein complex of human plasma: Interaction with fibrin and fibrinolysis. Thromb Res (submitted for publication)
    PubMedGoogle Scholar
  • 4 Lipinski B, Egyud LG. Thiol-induced crosslinking of human blood proteins: Implications for tumor immunity. Bioorg Medic Chem Lett 1992; 2: 919-925
    PubMedGoogle Scholar